Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study

scientific article published in June 2004

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1001/JAMA.291.24.2947
P698PubMed publication ID15213206
P5875ResearchGate publication ID8495456

P50authorLeon J. ThalQ56839882
Cora E LewisQ87075032
Lewis KullerQ88077314
Marcia L. StefanickQ109542605
Kamal H MasakiQ114312000
Sally A ShumakerQ114424439
Stephen R. RappQ124352318
Laura H. CokerQ124354721
P2093author name stringSusan L Hendrix
Claudine Legault
Dorothy S Lane
Howard Fillit
Women's Health Initiative Memory Study
P433issue24
P407language of work or nameEnglishQ1860
P921main subjectmild cognitive impairmentQ1472703
estrogenQ277954
cognitive dysfunctionQ57859955
dementiaQ83030
P304page(s)2947-2958
P577publication date2004-06-01
P1433published inThe Journal of the American Medical AssociationQ1470970
P1476titleConjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study
P478volume291

Reverse relations

cites work (P2860)
Q34220854"I Am Hot, Irritable and Feeling Low; What Alternatives do I have Besides Hormone Replacement Therapy?".
Q3382573617α-estradiol attenuates neuron loss in ovariectomized Dtg AβPP/PS1 mice.
Q5603112117α-estradiol: a less-feminizing estrogen
Q57157080A Heartfelt Message, Estrogen Replacement Therapy: Use It or Lose It
Q37547427A cell-biased effect of estrogen in prion infection.
Q38846232A comparison of progestins within three classes: Differential effects on learning and memory in the aging surgically menopausal rat.
Q34316221A component of Premarin® enhances multiple cognitive functions and influences nicotinic receptor expression
Q33745024A cross-sectional study of hormone treatment and hippocampal volume in postmenopausal women: evidence for a limited window of opportunity
Q46794182A double-blind, placebo-controlled trial of donepezil for the treatment of menopause-related cognitive loss
Q35986045A lack of ovarian function increases neuroinflammation in aged mice
Q38316448A major role for cardiovascular burden in age-related cognitive decline
Q33925274A new approach to understanding the molecular mechanisms through which estrogens affect cognition
Q36797166A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE Trial
Q30491831A theory of eu-estrogenemia: a unifying concept
Q90263988Accelerated Ovarian Failure as a Unique Model to Study Peri-Menopause Influence on Alzheimer's Disease
Q36990320Adjusting for mortality when identifying risk factors for transitions to mild cognitive impairment and dementia
Q35322167Advances in the prevention of Alzheimer's disease and dementia
Q55395274Age at menopause and lifetime cognition: Findings from a British birth cohort study.
Q37623629Age-dependent Effects of 17β-estradiol on the dynamics of estrogen receptor β (ERβ) protein-protein interactions in the ventral hippocampus
Q36511909Age-related changes in neuroprotection: is estrogen pro-inflammatory for the reproductive senescent brain?
Q36721813Age-related inflammatory diseases: role of genetics and gender in the pathophysiology of Alzheimer's disease
Q36164324Aging and Loss of Circulating 17β-Estradiol Alters the Alternative Splicing of ERβ in the Female Rat Brain
Q36795162Aging and substitutive hormonal therapy influence in regional and subcellular distribution of ERα in female rat brain
Q36633134Aging of brain: role of estrogen.
Q37470780Aging, estrogens, and episodic memory in women
Q34593121Allopregnanolone impairs episodic memory in healthy women
Q58452030Alzheimer's Disease
Q37272133Alzheimer's Disease in Adults with Down Syndrome
Q64163825Alzheimer's Disease: Progress in the Development of Anti-amyloid Disease-Modifying Therapies
Q34039983Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments
Q36026972Alzheimer's and dementia in the oldest-old: a century of challenges
Q29616743Alzheimer's disease
Q36894385Alzheimer's disease and mild cognitive impairment
Q36946824Alzheimer's disease and other neurological disorders
Q30620862Alzheimer's disease, dementia, mild cognitive impairment and the menopause: a 'window of opportunity'?
Q57074482Alzheimer's disease, estrogens, and clinical trials: a case study in drug development for complex disorders
Q38871979Alzheimer's disease, menopause and the impact of the estrogenic environment
Q37315515Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause
Q33773031Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible
Q35987458Ambient air pollution and neurotoxicity on brain structure: Evidence from women's health initiative memory study
Q46129248An omnibus test for several hazard alternatives in prevention randomized controlled clinical trials
Q34719941An update on hormone replacement therapy: health and medicine for women: a multidisciplinary, evidence-based review of mid-life health concerns.
Q37084906An update on the cognitive impact of clinically-used hormone therapies in the female rat: models, mazes, and mechanisms
Q33896147An update on the diagnosis and management of dementing conditions
Q37576090An update on treatment and prevention strategies for Alzheimer's disease
Q31029649Analysing Time to Event Data in Dementia Prevention Trials: The Example of the GuidAge Study of EGb761.
Q34810472Application of machine learning methods to describe the effects of conjugated equine estrogens therapy on region-specific brain volumes
Q35237981Ascertaining dementia-related outcomes for deceased or proxy-dependent participants: an overview of the Women's Health Initiative Memory Study supplemental case ascertainment protocol
Q37015181Assessment of estradiol influence on spatial tasks and hippocampal CA1 spines: evidence that the duration of hormone deprivation after ovariectomy compromises 17beta-estradiol effectiveness in altering CA1 spines
Q38392550Association of bilateral oophorectomy with cognitive function in healthy, postmenopausal women
Q38129325Atypical aging in Down syndrome
Q50783742Benchmarks for designing two-stage studies using modified mini-mental state examinations: experience from the Women's Health Initiative Memory Study.
Q37483121Benefits of Hormone Therapy Estrogens Depend on Estrogen Type: 17β-Estradiol and Conjugated Equine Estrogens Have Differential Effects on Cognitive, Anxiety-Like, and Depressive-Like Behaviors and Increase Tryptophan Hydroxylase-2 mRNA Levels in Dor
Q35072737Benzothiophene Selective Estrogen Receptor Modulators Provide Neuroprotection by a novel GPR30-dependent Mechanism
Q24643351Bioidentical hormones for menopausal hormone therapy: variation on a theme
Q91984204Blood pressure variability and brain morphology in elderly women without cardiovascular disease
Q34708973Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review
Q36650676Brain endogenous estrogen levels determine responses to estrogen replacement therapy via regulation of BACE1 and NEP in female Alzheimer's transgenic mice
Q34091893Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease
Q37413116Brain volumes, cognitive impairment, and conjugated equine estrogens
Q36349176Brain-derived neurotrophic factor Val(66)Met genotype and ovarian steroids interactively modulate working memory-related hippocampal function in women: a multimodal neuroimaging study
Q36106017Building a better hormone therapy? How understanding the rapid effects of sex steroid hormones could lead to new therapeutics for age-related memory decline.
Q36843004CAP--advancing the evaluation of preclinical Alzheimer disease treatments
Q91825612CB1 agonism prolongs therapeutic window for hormone replacement in ovariectomized mice
Q36463375Calcium and vitamin D supplementation and cognitive impairment in the women's health initiative
Q36130681Can endocrine disruptors influence neuroplasticity in the aging brain?
Q35625177Cancer and Dementia: It's Complicated
Q37688153Cardiovascular disease is preventable among women
Q36892860Care of the menopausal patient: a nurse practitioner's view
Q34361818Characteristics of hormone therapy, cognitive function, and dementia: the prospective 3C Study.
Q99573908Characterizing the effects of tonic 17β-estradiol administration on spatial learning and memory in the follicle-deplete middle-aged female rat
Q34978792Chronic treatment with the nitric oxide synthase inhibitor, L-NAME, attenuates estradiol-mediated improvement of learning and memory in ovariectomized rats
Q37477478Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences.
Q31155412Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology
Q36632771Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology
Q37810697Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology
Q37088621Cognitive changes after menopause: influence of estrogen
Q36919235Cognitive decline and dementia in the oldest-old
Q45960420Cognitive effects of short-term use of raloxifene: a randomized clinical trial.
Q36539736Cognitive performance in healthy women during induced hypogonadism and ovarian steroid addback
Q92656269Cognitive resilience among APOE ε4 carriers in the oldest old
Q48305628Cognitive symptoms during the menopausal transition and early postmenopause
Q37207741Cognitive-impairing effects of medroxyprogesterone acetate in the rat: independent and interactive effects across time
Q37352376Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Prevention trials in persons at risk for dominantly inherited Alzheimer's disease: opportunities and challenges
Q24186056Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates
Q37650744Complexities of oestrogen in stroke
Q36948674Conjugated equine estrogen enhances rats' cognitive, anxiety, and social behavior
Q30659580Conjugated estrogens for the treatment of menopausal symptoms: a review of safety data
Q47568706Consensus Approaches to Identify Incident Dementia in Cohort Studies: Systematic Review and Approach in the Successful Aging after Elective Surgery Study
Q33600226Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years
Q33874451Continuous and cyclic progesterone differentially interact with estradiol in the regulation of Alzheimer-like pathology in female 3xTransgenic-Alzheimer's disease mice
Q36095863Continuous estrone treatment impairs spatial memory and does not impact number of basal forebrain cholinergic neurons in the surgically menopausal middle-aged rat
Q34185639Continuous versus cyclic progesterone exposure differentially regulates hippocampal gene expression and functional profiles
Q37642394Continuously delivered ovarian steroids do not alter dendritic spine density or morphology in macaque dorsolateral prefrontal cortical neurons
Q30634935Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies
Q34067487Current treatment and recent clinical research in Alzheimer's disease
Q36575001Current treatment of mild cognitive impairment and Alzheimer's disease
Q38778638Defeating Alzheimer's disease and other dementias: a priority for European science and society
Q33924014Dementia and cognitive impairment: epidemiology, diagnosis, and treatment
Q64109996Dementia outcomes after addition of proxy-based assessments for deceased or proxy-dependent participants
Q37263684Dementia prevention: methodological explanations for inconsistent results
Q36787352Dementia syndromes: evaluation and treatment
Q35994372Dementia: finding the signals in the noise
Q33915401Demographic and health factors associated with enrollment in posttrial studies: the Women's Health Initiative Hormone Therapy Trials
Q48930833Depressive symptoms and incidence of mild cognitive impairment and probable dementia in elderly women: the Women's Health Initiative Memory Study
Q39657169Depressive symptoms, antidepressant use, and future cognitive health in postmenopausal women: the Women's Health Initiative Memory Study
Q35028141Depressive symptoms, brain volumes and subclinical cerebrovascular disease in postmenopausal women: the Women's Health Initiative MRI Study
Q34216817Development of subtype-selective oestrogen receptor-based therapeutics.
Q24646877Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease
Q43196397Diet and the risk for Alzheimer's disease
Q35005274Dietary inflammation factor rating system and risk of Alzheimer disease in elders.
Q45841349Differences Between Gynecologists and Primary Care Physicians in Hormone Therapy Prescribing: Why They Matter
Q34494238Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD.
Q36818199Differential effects of estrogen and micronized progesterone or medroxyprogesterone acetate on cognition in postmenopausal women
Q37143947Differential effects on visual and spatial recognition memory of a novel hormone therapy regimen of estrogen alone or combined with progesterone in older surgically menopausal monkeys
Q35029513Do aromatase inhibitors have adverse effects on cognitive function?
Q37332321Donepezil treatment restores the ability of estradiol to enhance cognitive performance in aged rats: evidence for the cholinergic basis of the critical period hypothesis
Q37157784Dose-dependent effects of post-training estradiol plus progesterone treatment on object memory consolidation and hippocampal extracellular signal-regulated kinase activation in young ovariectomized mice
Q36826910Driving with Mild Cognitive Impairment or Dementia: Cognitive Test Performance and Proxy Report of Daily Life Function in Older Women
Q34320568Duration of estrogen deprivation, not chronological age, prevents estrogen's ability to enhance hippocampal synaptic physiology
Q51037908EFNS guidelines for the diagnosis and management of Alzheimer's disease.
Q37113841Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition
Q35498087Early initiation of hormone therapy in menopausal women is associated with increased hippocampal and posterior cingulate cholinergic activity
Q33981652Early menopausal hormone use influences brain regions used for visual working memory
Q37460286Early, but not late onset estrogen replacement therapy prevents oxidative stress and metabolic alterations caused by ovariectomy.
Q28071845Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer's Disease
Q46459550Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men.
Q28384228Effect of dietary legumes on bone-specific gene expression in ovariectomized rats
Q36684570Effects of Hormone Therapy on Brain Volumes Changes of Postmenopausal Women Revealed by Optimally-Discriminative Voxel-Based Morphometry
Q51144893Effects of chronic oestradiol, progesterone and medroxyprogesterone acetate on hippocampal neurogenesis and adrenal mass in adult female rats.
Q37417437Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy
Q46528069Effects of estrogen and estrogenic compounds on cognition in ovariectomized rats
Q46731148Effects of estrogen and progestin on hypothalamic blood flow autoregulation
Q33552696Effects of hormone replacement therapy on magnetic resonance imaging of brain parenchyma hyperintensities in postmenopausal women
Q26865143Effects of hormone therapy on cognition and mood
Q33889042Effects of long-term treatment with 17 beta-estradiol and medroxyprogesterone acetate on water maze performance in middle aged female rats
Q48100705Effects of long-term, low-dose sex hormone replacement therapy on hippocampus and cognition of postmenopausal women of different apoE genotypes.
Q41442478Effects of synaptic plasticity regulated by 17beta-estradiol on learning and memory in rats with Alzheimer's disease
Q37439245Effects of two years of conjugated equine estrogens on cholinergic neurons in young and middle-aged ovariectomized monkeys
Q34959106Endocrine disruptors as a threat to neurological function
Q37141534Endpoints for trials in Alzheimer's disease: a European task force consensus
Q35915312Enrollment in a brain magnetic resonance study: results from the Women's Health Initiative Memory Study Magnetic Resonance Imaging Study (WHIMS-MRI).
Q36546512Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer's disease
Q37947688Epidemiological findings of vascular risk factors in Alzheimer's disease: implications for therapeutic and preventive intervention
Q34991223Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention
Q40069328Epidemiology of estrogen and dementia in women with Down syndrome
Q57781941Epidemiology of neurological diseases in elderly people: what did we learn from the Rotterdam Study?
Q38708380Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS).
Q37085132Estradiol and neurodegenerative oxidative stress
Q37484251Estradiol and the relationship between dendritic spines, NR2B containing NMDA receptors, and the magnitude of long-term potentiation at hippocampal CA3-CA1 synapses
Q48330937Estradiol enhances neurogenesis following ischemic stroke through estrogen receptors alpha and beta
Q36732302Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: evidence for the critical period hypothesis
Q36713849Estradiol or diarylpropionitrile administration to wild type, but not estrogen receptor beta knockout, mice enhances performance in the object recognition and object placement tasks
Q36745218Estradiol reduces anxiety- and depression-like behavior of aged female mice
Q33875866Estradiol replacement extends the window of opportunity for hippocampal function
Q33779918Estradiol-induced object memory consolidation in middle-aged female mice requires dorsal hippocampal extracellular signal-regulated kinase and phosphatidylinositol 3-kinase activation
Q33558982Estrogen Secreted by Mesenchymal Stem Cells Necessarily Determines Their Feasibility of Therapeutical Application.
Q30478476Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines
Q92345807Estrogen activates Alzheimer's disease genes
Q50891302Estrogen administration negatively alters mood following monoaminergic depletion and psychosocial stress in postmenopausal women.
Q42491540Estrogen alters spine number and morphology in prefrontal cortex of aged female rhesus monkeys.
Q37076464Estrogen and comprehension of metaphoric speech in women suffering from schizophrenia: results of a double-blind, placebo-controlled trial
Q36039975Estrogen and memory in women: how can we reconcile the findings?
Q24658109Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society
Q34784469Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases
Q33591732Estrogen deficiency is associated with hippocampal morphological remodeling of early postmenopausal mice
Q42436195Estrogen effects on high-affinity choline uptake in primary cultures of rat basal forebrain
Q33929847Estrogen intake and copper depositions: implications for Alzheimer's disease?
Q30480285Estrogen modifies arousal but not memory for emotional events in older women
Q48488958Estrogen receptor alpha and APOEepsilon4 polymorphisms interact to increase risk for sporadic AD in Italian females
Q90222498Estrogen receptor α promotes Cav1.2 ubiquitination and degradation in neuronal cells and in APP/PS1 mice
Q36322578Estrogen receptor β in Alzheimer's disease: From mechanisms to therapeutics
Q34360055Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease
Q37675866Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease
Q51001119Estrogen replacement therapy and cognitive functions in healthy postmenopausal women: a randomized trial.
Q46058009Estrogen replacement therapy, Alzheimer's disease, and mild cognitive impairment
Q21284766Estrogen signaling and the aging brain: context-dependent considerations for postmenopausal hormone therapy
Q92042117Estrogen sulfotransferase in the metabolism of estrogenic drugs and in the pathogenesis of diseases
Q36677805Estrogen synthesis and signaling pathways during aging: from periphery to brain
Q46233165Estrogen therapy affects right hemisphere functioning in postmenopausal women
Q48335998Estrogen therapy and brain muscarinic receptor density in healthy females: a SPET study
Q33779694Estrogen therapy and cognition: a review of the cholinergic hypothesis
Q37618547Estrogen therapy: is time of initiation critical for neuroprotection?
Q46947447Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal postmenopausal women
Q34144464Estrogen treatment impairs cognitive performance after psychosocial stress and monoamine depletion in postmenopausal women
Q99345086Estrogen, brain structure, and cognition in postmenopausal women
Q34585797Estrogen, cognition and female ageing
Q36621171Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women.
Q33623924Estrogen: a master regulator of bioenergetic systems in the brain and body
Q34583150Estrogen: effects on normal brain function and neuropsychiatric disorders.
Q28079898Estrogenic Endocrine Disrupting Chemicals Influencing NRF1 Regulated Gene Networks in the Development of Complex Human Brain Diseases
Q80815527Estrogens and Stroke: Use of Oral Contraceptives and Postmenopausal Use of Estrogen: Current Recommendations
Q37147787Estrogens and age-related memory decline in rodents: what have we learned and where do we go from here?
Q36980880Estrogens and progesterone as neuroprotectants: what animal models teach us
Q38739583Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury
Q36931711Estrogens, episodic memory, and Alzheimer's disease: a critical update
Q34269755Estrogens, estrogen receptors, and female cognitive aging: the impact of timing
Q35193759Evidence regarding the benefits of physical exercise
Q50600187Executive functions in men and postmenopausal women.
Q49586649FSH to estradiol ratio can be used as screening method for mild cognitive impairment in postmenopausal women
Q36901959Factors influencing the cognitive and neural effects of hormone treatment during aging in a rodent model
Q37090625Familial Alzheimer disease in Latinos: interaction between APOE, stroke, and estrogen replacement
Q56673117Five Decades of Hormone Therapy Research: The Long, the Short, and the Inconclusive
Q35034379Folate, vitamin B-6, and vitamin B-12 intake and mild cognitive impairment and probable dementia in the Women's Health Initiative Memory Study.
Q37324566Frontiers proposal. National Institute on Aging "bench to bedside: estrogen as a case study".
Q35816802Functional decline associated with polypharmacy and potentially inappropriate medications in community-dwelling older adults with dementia
Q92543481GABA-A receptor modulating steroids in acute and chronic stress; relevance for cognition and dementia?
Q33565734GC-TOF/MS-based metabolomic profiling of estrogen deficiency-induced obesity in ovariectomized rats
Q34612871GPR30 is positioned to mediate estrogen effects on basal forebrain cholinergic neurons and cognitive performance
Q35534146Galanthamine plus estradiol treatment enhances cognitive performance in aged ovariectomized rats
Q92542344Gender Difference in the Effects of Outdoor Air Pollution on Cognitive Function Among Elderly in Korea
Q38225583Gender and cataract--the role of estrogen
Q41717521Gender differences measured by the MATRICS consensus cognitive battery in chronic schizophrenia patients
Q36089835Gender modulates the APOE ε4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels
Q42363857Genetic Analysis of Mitochondrial Ribosomal Proteins and Cognitive Aging in Postmenopausal Women
Q37795699Genetic variability in estrogen disposition: Potential clinical implications for neuropsychiatric disorders
Q36227902Geographic Elevation and Cognitive Function among Elderly Residents in Rural Mountainous Areas: Shimane CoHRE Study
Q37028001Global cognitive function before, surrounding, and after ischemic stroke: the role of risk and protective factors varies with time among ischemic stroke survivors
Q36909207Gonadal hormones and cognitive aging: a midlife perspective
Q36914297Guarding the blood-brain barrier: a role for estrogen in the etiology of neurodegenerative disease.
Q53597256Guidelines for hormone replacement therapy of Asian women during the menopausal transition and thereafter.
Q22306361Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Q36755714Higher levels of estradiol replacement correlate with better spatial memory in surgically menopausal young and middle-aged rats
Q52147336Hippocampal Lipid Homeostasis in APP/PS1 Mice is Modulated by a Complex Interplay Between Dietary DHA and Estrogens: Relevance for Alzheimer's Disease.
Q34680911Hormonal influences on cognition and risk for Alzheimer's disease
Q37029421Hormonal treatment, mild cognitive impairment and Alzheimer's disease
Q24242542Hormone replacement therapy for cognitive function in postmenopausal women
Q36668526Hormone replacement therapy in menopausal women: Past problems and future possibilities
Q24241789Hormone replacement therapy to maintain cognitive function in women with dementia
Q36240364Hormone replacement therapy: an update
Q36475295Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study.
Q37381044Hormone therapy and cognitive function
Q36887336Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on.
Q38975101Hormone-replacement therapy: current thinking
Q36362593Hormones and menopause: pro.
Q35876440Hypertension and dementia: does blood pressure control favorably affect cognition?
Q36492399Hypertension, Dietary Sodium, and Cognitive Decline: Results From the Women's Health Initiative Memory Study
Q34626471IMS updated recommendations on postmenopausal hormone therapy
Q36311674Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women
Q37764494Impact of the hypothalamic-pituitary-adrenal/gonadal axes on trajectory of age-related cognitive decline
Q36976420In vivo profiling of estrogen receptor/specificity protein-dependent transactivation
Q34316296Increased memory load-related frontal activation after estradiol treatment in postmenopausal women
Q24645015Increased mortality for neurological and mental diseases following early bilateral oophorectomy
Q28584559Individually modifiable risk factors to ameliorate cognitive aging: a systematic review and meta-analysis
Q36268931Influences of hormone replacement therapy on olfactory and cognitive function in postmenopausal women
Q26863428Insights into rapid modulation of neuroplasticity by brain estrogens
Q28394967Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors
Q35958716Interviews With Two Women's Health Experts On the Use of Estrogen Therapies.
Q37436161Intraindividual variability in domain-specific cognition and risk of mild cognitive impairment and dementia
Q37018510Is timing everything? New insights into why the effect of estrogen therapy on memory might be age dependent
Q36970351Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8-9, 2007.
Q38831286L-Type Calcium Channels Modulation by Estradiol
Q33854590Lack of association of acute phase response proteins with hormone levels and antidepressant medication in perimenopausal depression
Q36176198Life-long environmental enrichment differentially affects the mnemonic response to estrogen in young, middle-aged, and aged female mice.
Q24647962Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist
Q24201974Long term hormone therapy for perimenopausal and postmenopausal women
Q24241279Long term hormone therapy for perimenopausal and postmenopausal women
Q24246577Long term hormone therapy for perimenopausal and postmenopausal women
Q35616166Long-term consequences of estrogens administered in midlife on female cognitive aging
Q37277562Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging
Q34048789Long-term effects of conjugated equine estrogen therapies on domain-specific cognitive function: results from the Women's Health Initiative study of cognitive aging extension
Q37352051Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years
Q51974359Long-term estrogen therapy and 5-HT(2A) receptor binding in postmenopausal women; a single photon emission tomography (SPET) study.
Q36089352Long-term health consequences of premature or early menopause and considerations for management
Q30238978Long-term hormone therapy for perimenopausal and postmenopausal women
Q35718091Long-term replacement of estrogen in combination with medroxyprogesterone acetate improves acquisition of an alternation task in middle-aged female rats
Q41102759Long-term use of tamoxifen reduces the risk of dementia: a nationwide population-based cohort study
Q36456541Longer duration of hormonal contraceptive use predicts better cognitive outcomes later in life
Q37001444Longitudinal study of low serum LDL cholesterol and depressive symptom onset in postmenopause
Q33591187Lost in translation: epidemiology, risk, and Alzheimer disease
Q92648681Low-fat dietary pattern and global cognitive function: Exploratory analyses of the Women's Health Initiative (WHI) randomized Dietary Modification trial
Q57492371Luteinizing Hormone Involvement in Aging Female Cognition: Not All Is Estrogen Loss
Q58485914Maintaining cognitive health in elderly women
Q35742248Managing the menopause.
Q37322698Manipulation of Ovarian Function Significantly Influenced Sarcopenia in Postreproductive-Age Mice
Q35882023Manipulation of Ovarian Function Significantly Influenced Trabecular and Cortical Bone Volume, Architecture and Density in Mice at Death
Q37245953Mechanisms enforcing the estrogen receptor β selectivity of botanical estrogens
Q37048086Medical management of frontotemporal dementia
Q22242806Medications and Diet
Q92132021Medroxyprogesterone Acetate Impairs Amyloid Beta Degradation in a Matrix Metalloproteinase-9 Dependent Manner
Q35168390Medroxyprogesterone acetate antagonizes estrogen up-regulation of brain mitochondrial function
Q30465714Medroxyprogesterone acetate impairs memory and alters the GABAergic system in aged surgically menopausal rats.
Q40045531Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials
Q37349131Menopausal Hormone Therapy, Age, and Chronic Diseases: Perspectives on Statistical Trends
Q36152764Menopausal hormone therapy
Q37658616Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials
Q37822795Menopause and mental well-being: timing of symptoms and timing of hormone treatment
Q43028519Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy
Q34356193Menopause effects on verbal memory: findings from a longitudinal community cohort
Q21131065Menopause, obesity and inflammation: interactive risk factors for Alzheimer's disease
Q37030684Menopause: developing a rational treatment plan
Q34347589MicroRNAs in the aging female brain: a putative mechanism for age-specific estrogen effects.
Q26994975Mild cognitive impairment and dementia: the importance of modifiable risk factors
Q34572010Mild cognitive impairment: The dilemma.
Q36113990Minireview: translational animal models of human menopause: challenges and emerging opportunities
Q28392016Modeling menopause: The utility of rodents in translational behavioral endocrinology research
Q38243574Molecular signature of rapid estrogen regulation of synaptic connectivity and cognition
Q31122463Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board
Q36611546Mortality in women given diethylstilbestrol during pregnancy.
Q36756290Multiple clinically relevant hormone therapy regimens fail to improve cognitive function in aged ovariectomized rhesus monkeys
Q51692831Neighborhood socioeconomic status and cognitive function in women.
Q24630024Neurobiological Underpinnings of the Estrogen - Mood Relationship
Q64460778Neuroimmunology of the female brain across the lifespan: Plasticity to psychopathology
Q57823065Neurological health and premature ovarian insufficiency - pathogenesis and clinical management
Q38005895Neuroprotection and estrogen receptors
Q37479919Neuroprotective actions of selective estrogen receptor modulators.
Q41100832Neuroprotective and Memory-Enhancing Effect of the Combined Extract of Purple Waxy Corn Cob and Pandan in Ovariectomized Rats.
Q33762953Neuroprotective effects of estrogen therapy for cognitive and neurobiological profiles of monkey models of menopause
Q35078498Neuroscientists as cartographers: mapping the crossroads of gonadal hormones, memory and age using animal models
Q35779578Neurosteroid effects at α4βδ GABAA receptors alter spatial learning and synaptic plasticity in CA1 hippocampus across the estrous cycle of the mouse
Q35971833Neurosteroids and GABA-A Receptor Function
Q46407690New thoughts about estrogen therapy from the Women's Health Initiative
Q31070019No Association between Dietary Patterns and Risk for Cognitive Decline in Older Women with 9-Year Follow-Up: Data from the Women's Health Initiative Memory Study
Q50935037No differences in performance on test of working memory and executive functioning between healthy elderly postmenopausal women using or not using hormone therapy.
Q36459049Novel mechanisms for estrogen-induced neuroprotection
Q37283496Number of children is associated with neuropathology of Alzheimer's disease in women
Q46828775Oestrogen doesn't protect mental function in older women
Q46799979Oestrogen receptor α agonist improved long-term ovariectomy-induced spatial cognition deficit in young rats
Q36690367Oestrogen, cognition and the maturing female brain.
Q33677382Omega-3 fatty acids and cognitive function in women
Q26853730Oophorectomy, estrogen, and dementia: a 2014 update
Q34612492Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity
Q33808780Oophorectomy, menopause, estrogen, and cognitive aging: the timing hypothesis
Q60954733Ovarian Cycle Stages Modulate Alzheimer-Related Cognitive and Brain Network Alterations in Female Mice
Q37633232Particulate air pollutants, APOE alleles and their contributions to cognitive impairment in older women and to amyloidogenesis in experimental models
Q34478669Pharmacological strategies for the prevention of Alzheimer's disease
Q37004359Pharmacotherapy of Alzheimer disease
Q47582925Polymorphisms of the estrogen receptor alpha (ESR1) gene and the risk of Alzheimer's disease in a southern Chinese community
Q43154107Post hoc magnetic resonance imaging cannot justify the conclusions of WHIMS.
Q42840295Postmenopausal hormone therapy
Q37742148Postmenopausal hormone therapy and Alzheimer disease: A prospective cohort study
Q27008086Postmenopausal hormone therapy and cognition
Q51861170Postmenopausal hormone therapy and cognition: effects of timing and treatment type.
Q33516441Postmenopausal hormone therapy and cognitive outcomes: the Women's Health Initiative Memory Study (WHIMS).
Q37180441Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study
Q37180460Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI Study
Q34420014Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke
Q37416371Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer's disease
Q36355137Postmenopausal hormone therapy, timing of initiation, APOE and cognitive decline
Q36156641Postmenopausal hormone therapy, type 2 diabetes mellitus, and brain volumes
Q30451123Postmenopausal hormone therapy: an Endocrine Society scientific statement.
Q38082563Postmenopausal hormone therapy: risks and benefits
Q89562164Postmenopausal hormone treatment alters neural pathways but does not improve verbal cognitive function
Q36661099Potential Role of Oestrogen Modulation in the Treatment of Neurocognitive Deficits in Schizophrenia
Q46664316Potential health benefits of continuous LNG-IUS combined with parenteral ERT for seamless menopausal transition and beyond--a commentary based on clinical experience
Q37418919Potential role of estrogen in the pathobiology and prevention of Alzheimer's disease.
Q34312062Predicting Alzheimer's disease in the Baltimore longitudinal study of aging
Q40283154Preeclampsia and cognitive impairment later in life
Q36296643Preliminary evidence that long-term estrogen use reduces white matter loss in aging
Q37417828Premarin improves memory, prevents scopolamine-induced amnesia and increases number of basal forebrain choline acetyltransferase positive cells in middle-aged surgically menopausal rats
Q33278956Premature ovarian failure: a review
Q34847609Preventing Alzheimer's disease : separating fact from fiction
Q37001410Preventing cognitive decline in healthy older adults
Q38719665Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives
Q34683795Prevention of Alzheimer disease. Encouraging evidence.
Q22248031Prevention of Alzheimer's disease
Q53499870Prevention of Alzheimer's disease, cerebrovascular disease and dementia in women: the case for menopause hormone therapy.
Q38554910Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions
Q38983318Prevention studies in Alzheimer's disease: progress towards the development of new therapeutics
Q88615781Previous estradiol treatment in ovariectomized mice provides lasting enhancement of memory and brain estrogen receptor activity
Q37670673Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward
Q36806653Primary prevention and delay of onset of AD/dementia
Q37072797Progesterone influence on neurite outgrowth involves microglia.
Q37220808Progesterone reduces depression-like behavior in a murine model of Alzheimer's Disease
Q36436653Prognostic factors in paediatric anaplastic large cell lymphoma: role of ALK.
Q36545649Prolonged ovarian hormone deprivation alters the effects of 17β-estradiol on microRNA expression in the aged female rat hypothalamus
Q33544151Promoting successful cognitive aging: a comprehensive review
Q33851285Promotional tone in reviews of menopausal hormone therapy after the Women's Health Initiative: an analysis of published articles
Q35119064Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia
Q37309638Protective actions of sex steroid hormones in Alzheimer's disease
Q36972735Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogen-mediated neuroprotection
Q37261100Provider attributes associated with hormone therapy prescribing frequency
Q34125853Psychiatric disorders and cognitive dysfunction among older, postmenopausal women: results from the Women's Health Initiative Memory Study
Q90666336Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer
Q35972436Rapid estradiol modulation of neuronal connectivity and its implications for disease
Q37063691Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS Cognitive and Affective sub study (KEEPS Cog)
Q36380901Re-Opening the Critical Window for Estrogen Therapy
Q36946779Recent epidemiological evidence relevant to the clinical management of the menopause
Q38002365Recruitment methods for United States Alzheimer disease prevention trials
Q33831158Relationship of hypertension, blood pressure, and blood pressure control with white matter abnormalities in the Women's Health Initiative Memory Study (WHIMS)-MRI trial
Q33841626Relative effects of tamoxifen, raloxifene, and conjugated equine estrogens on cognition
Q49957773Reproductive endocrinology: Postmenopausal hormone therapy to prevent chronic conditions
Q56031122Review of the effects of 17α-estradiol in humans: a less feminizing estrogen with neuroprotective potential
Q37889475Risk profiles of Alzheimer disease
Q24647700Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence
Q46633788Role of protein phosphatases in estrogen-mediated neuroprotection.
Q37014605Role of psychiatric comorbidity on cognitive function during and after the menopausal transition
Q24625569Roles for oestrogen receptor β in adult brain function
Q36794420SERMs for the treatment and prevention of breast cancer
Q38700757Safety and benefit considerations for menopausal hormone therapy
Q33236269Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disea
Q40430713Serum lipid changes following the onset of depressive symptoms in postmenopausal women
Q90250191Sex Differences in Cardiovascular Disease and Cognitive Impairment: Another Health Disparity for Women?
Q38878236Sex Hormones and Cognition: Neuroendocrine Influences on Memory and Learning
Q92023923Sex and Gender Differences in Alzheimer's Disease Dementia
Q34214272Sex and gender differences in the causes of dementia: a narrative review
Q36473640Sex and gonadal hormones in mouse models of Alzheimer's disease: what is relevant to the human condition?
Q50506777Sex and post-menopause hormone therapy effects on hippocampal volume and verbal memory.
Q37432182Sex and the development of Alzheimer's disease.
Q33864547Sex differences in cognitive impairment and Alzheimer's disease
Q82035418Sex differences in stroke
Q49601287Sex-related differences in oxidative stress and neurodegeneration
Q36758718Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause
Q46342146Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study
Q56505904Single-Sex Education and the Brain
Q36373516Sleep duration, cognitive decline, and dementia risk in older women
Q90074464Statin therapy: does sex matter?
Q38242935Steroid hormones, receptors, and perceptual and cognitive sex differences in the visual system
Q37714345Stroke in women
Q34088579Subtypes of mild cognitive impairment in older postmenopausal women: the Women's Health Initiative Memory Study
Q43424580Sugary foods and gynecological cancer risk
Q35641917Suppression of beta-amyloid precursor protein signaling into the nucleus by estrogens mediated through complex formation between the estrogen receptor and Fe65.
Q58582917Synaptic distributions of pS214-tau in rhesus monkey prefrontal cortex are associated with spine density, but not with cognitive decline
Q35016901Targeting gonadotropins: an alternative option for Alzheimer disease treatment
Q36475967Testosterone replacement therapy for late-onset hypogonadism
Q58614226The Association Between Body Mass Index, and Cognitive, Functional, and Behavioral Declines for Incident Dementia
Q33873941The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onset
Q21563448The Haunting of Medical Journals: How Ghostwriting Sold “HRT”
Q35200989The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition
Q38927944The Potential of Gonadal Hormone Signalling Pathways as Therapeutics for Dementia.
Q46797789The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline
Q33275630The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial
Q40190946The association between an inflammatory diet and global cognitive function and incident dementia in older women: The Women's Health Initiative Memory Study.
Q30496612The cognitive effects of conjugated equine estrogens depend on whether menopause etiology is transitional or surgical
Q36704008The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature?
Q27693353The diagnosis and management of mild cognitive impairment: a clinical review
Q37244686The differences in neuroprotective efficacy of progesterone and medroxyprogesterone acetate correlate with their effects on brain-derived neurotrophic factor expression
Q45247132The effect of cyclooxygenase-2 inhibitors on bone mineral density: results from the Canadian Multicentre Osteoporosis Study
Q37172024The effects of acute 17beta-estradiol treatment on gene expression in the young female mouse hippocampus.
Q48130002The effects of chronic estradiol treatment on working memory deficits induced by combined infusion of beta-amyloid (1-42) and ibotenic acid
Q37390076The expanding use of third-generation aromatase inhibitors: what the general internist needs to know
Q33921182The neurotoxic effects of estrogen on ischemic stroke in older female rats is associated with age-dependent loss of insulin-like growth factor-1.
Q28263673The potential for estrogens in preventing Alzheimer's disease and vascular dementia
Q36933312The rationale, design, and baseline characteristics of the Women's Health Initiative Memory Study of Younger Women (WHIMS-Y).
Q36304876The role of allelic variation in estrogen receptor genes and major depression in the Nurses Health Study
Q37145381The role of hormone therapy and calcium plus vitamin D for reduction of bone loss and risk for fractures: lessons learned from the Women's Health Initiative
Q38609082The role of menopausal hormone therapy in the management of osteoporosis
Q61965640The timing of estrogen therapy after ovariectomy—implications for neurocognitive function
Q34536301Three midlife strategies to prevent cognitive impairment due to Alzheimer's disease
Q34168826Thyroid Hormones Are Associated with Poorer Cognition in Mild Cognitive Impairment
Q89308533Timing of cyclic estradiol treatment differentially affects cognition in aged female rhesus monkeys
Q34683673Timing of hormone therapy and dementia: the critical window theory revisited
Q34468841Tonic Premarin dose-dependently enhances memory, affects neurotrophin protein levels and alters gene expression in middle-aged rats.
Q28600847Trajectories and phenotypes with estrogen exposures across the lifespan: What does Goldilocks have to do with it?
Q34684381Translational research on the way to effective therapy for Alzheimer disease
Q47148252Treatment of Alzheimer's disease in Brazil: I. Cognitive disorders
Q36213129Treatment of menopausal symptoms: what shall we do now?
Q36784455Treatment of the mild cognitive impairment (MCI).
Q35941842Update on the effect of estradiol in postmenopause women with Alzheimer's disease: a systematic review
Q38106748Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.
Q48671400Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health
Q64055802Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study
Q34038890Using genetics to enable studies on the prevention of Alzheimer's disease
Q30513312Using predictors of hormone therapy use to model the healthy user bias: how does healthy user status influence cognitive effects of hormone therapy?
Q34786018Utilization of antihypertensives, antidepressants, antipsychotics, and hormones in Alzheimer disease
Q28081565Utilizing induced pluripotent stem cells (iPSCs) to understand the actions of estrogens in human neurons
Q34425445What is the best evidence for determining harms of medical treatment?
Q53220661When practices, promises, profits, and policies outpace hard evidence: the post-menopausal hormone debate.
Q36350786Where are we with postmenopausal hormone therapy in 2005?
Q53282559[New therapeutic approaches in Alzheimer disease].
Q80252363[Preventing Alzheimer's disease: hopes and disappointments]
Q83950697[Should we change our attitude on postmenopausal hormone replacement therapy?]

Search more.